NL-OMON36006招募中不适用
A pilot study to explore the bioavailability of UMP enriched products in healthy volunteers - UMP Pilot Study
Danone Research - Centre for Specialised Nutrition0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-Age 50-70 years, inclusive
- •-BMI 18- 28kg/m2, inclusive
- •-Written informed consent
排除标准
- •-Any condition that may interfere with the definition *healthy volunteer* according to the investigator, with special attention to the presence of liver disease, bowel disease, diarrhea and catabolism (unintended recent weight loss)
- •-Heavy exercise like long-distance running one week prior to the study day
- •-The use of RNA rich nutritional supplements (such as yeast) within a period of one month prior to the start of the study
- •-Unable to adhere to protocol instructions
- •-Alcohol or drug abuse in the opinion of the investigator
- •-Investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements
- •-Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study
研究者
相似试验
进行中（未招募）
不适用
A study to compare a pediatric tablet or suspension of elvitegravir verses the adult 150 mg tablet in healthy adult volunteersHuman Immunodeficiency Virus (HIV-1) InfectionMedDRA version: 17.1Level: LLTClassification code 10020192Term: HIV-1System Organ Class: 100000004862EUCTR2015-000725-37-Outside-EU/EEAGilead Sciences, Inc.78
进行中（未招募）
不适用
Comparison of blood concentrations of tapentadol from 4 prolonged release formulations (3 granule formulations and 1 tablet formulation) in healthy adult subjects.o medical condition to be investigated.MedDRA version: 17.0Level: LLTClassification code 10049475Term: Chronic painSystem Organ Class: 100000004867EUCTR2012-005499-33-DEGrünenthal GmbH
已完成
1 期
A proof of concept study comparing the skin penetration abilities of the novel penetration enhancer Tocopheryl Phosphate Mix (TPM)/Diclofenac compared with Voltaren GelTransdermal drug deliveryMusculoskeletal conditionsMusculoskeletal - Other muscular and skeletal disordersMusculoskeletal - OsteoarthritisACTRN12608000574347Phosphagenics Limited12
已完成
1 期
Study to assess the distribution in the blood of healthy volunteers of a new formulation of losartan compared with the marketed formulation Cozaar® administered under fasting conditionsBioavailability of a new formulation of losartanISRCTN16928142DPL Pharma S.p.A.16
进行中（未招募）
1 期
Phase I Relative Bioavailability and food effect studyEUCTR2016-002895-29-DEBayer AG